Efficacy and safety of everolimus in combination with reduced tacrolimus in de novo liver transplant recipients: 36-month results from the randomized H2304 study

被引：0

作者：

Saliba, Faouzi ^{[1
]}

Kaiser, Gernot M. ^{[2
]}

De Carlis, Luciano ^{[3
]}

Metselaar, Herold J. ^{[4
]}

De Simone, Paolo ^{[5
]}

Duvoux, Christophe ^{[6
]}

Nevens, Frederik ^{[7
]}

Fischer, Lutz ^{[8
]}

Fung, John J. ^{[9
]}

Dong, Gaohong ^{[10
]}

Rauer, Barbara ^{[11
]}

Junge, Guido ^{[11
]}

机构：

[1] Hop Paul Brousse, Villejuif, France

[2] Univ Hosp Essen, Essen, Germany

[3] Osped Niguarda Ca Granda, Milan, Italy

[4] Univ Rotterdam Hosp, Erasmus MC, Rotterdam, Netherlands

[5] Azienda Osped Univ Pisana, Pisa, Italy

[6] Hop Henri Mondor, F-94010 Creteil, France

[7] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Louvain, Belgium

[8] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany

[9] Cleveland Clin Fdn, Cleveland, OH 44195 USA

[10] Novartis Pharmaceut, E Hanover, NJ USA

[11] Novartis Pharma AG, Basel, Switzerland

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

LB9

引用

页码：1383A / 1383A

页数：1